|
Volume
24 Number 21
15 November 2022
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
24, Year 2022 >
Number 21, 15 November
|
|
|
|
|
|
Fu X, Shi D, Feng Y.
The Efficacy
and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent
Glioblastoma: A Meta-analysis of Randomized Controlled
Studies.
Clin
Neuropharmacol. 2022 Nov-Dec 01;45(6):162-167→.
doi: 10.1097/WNF.0000000000000525→.
PMID: 36383914→.
Meta-analysis˰ →
|
|
|
|
Hosseinalizadeh H, Mahmoodpour M, Razaghi Bahabadi Z, Hamblin MR,
Mirzaei H.
Neutrophil mediated drug
delivery for targeted glioblastoma therapy: A comprehensive
review.
Biomed
Pharmacother. 2022 Nov 1, 2022;156:113841→.
doi: 10.1016/j.biopha.2022.113841→.
PMID: 36411657→.
Review.
→
|
|
|
|
Onishi S, Ohba S, Kuraoka K, Kurashige T, Sugiyama K, Yamasaki
F.
Molecular and clinical
characterization of H3 K27M-mutant "non-midline"
glioblastoma: A case report and literature review.
Neurocirugia
(Astur:Engl Ed). 2022 Nov 1, 2022;33(6):356-360→.
doi: 10.1016/j.neucie.2021.06.008→.
PMID: 36333093→.
Case report, Review˰ →
|
|
|
|
Wu L, Chai R, Zhao Z, Wang Q, Jiang T.
Role
of the tumor microenvironment in shaping IDH-wildtype glioma
plasticity, and potential therapeutic strategies.
Cancer
Biol Med. 2022 Nov 1, 2022;19(10):1423–7→.
doi: 10.20892/j.issn.2095-3941.2022.0363→.
PMID: 36350003→.
Editorial. →
|
|
|
|
Haddad AF, Aghi MK, Butowski N.
Novel
intraoperative strategies for enhancing tumor control: Future
directions.
Neuro
Oncol. 2022 Nov 2, 2022;24(S6):S25-S32→.
doi: 10.1093/neuonc/noac090→.
PMID: 36322096→.
Review.
→
|
|
|
|
Odia Y, Gutierrez AN, Kotecha R.
Stereotactic
targeted radiation therapy (STaRT) trials for brain neoplasms: A
comprehensive review. [GammaTile®]
Neuro
Oncol. 2022 Nov 2, 2022;24(S6):S16-S24→.
doi: 10.1093/neuonc/noac130→.
PMID: 36322100→.
Review. →
|
|
|
|
Schupper AJ, Chanenchuk T, Racanelli A, Price G, Hadjipanayis
CG.
Laser
hyperthermia: Past, present, and future. [LITT]
Neuro
Oncol. 2022 Nov 2, 2022;24(S6):S42-S51→.
doi: 10.1093/neuonc/noac208→.
PMID: 36322099→.
Review. →
|
|
|
|
Wu A, Wu JY, Lim M.
Updates in
intraoperative strategies for enhancing intra-axial brain tumor
control.
Neuro Oncol. 2022 Nov 2,
2022;24(S6):S33-S41→.
doi: 10.1093/neuonc/noac170→.
PMID: 36322098→.
Review. →
|
|
|
|
Bahadur S, Prakash A.
A
Comprehensive Review on Nanomedicine: Promising approach for
treatment of brain tumor through intranasal administration.
Curr
Drug Targets. 2022 Nov 3→.
doi: 10.2174/1389450124666221019141044→.
PMID: 36278468→.
Review˰ →
|
|
|
|
Khristov V, Lin A, Freedman Z, Staub J, Shenoy G, Mrowczynski O,
Rizk E, Zacharia B, Connor J.
Tumor-derived
Biomarkers in Liquid Biopsy of Glioblastoma.
World
Neurosurg. 2022 Nov 5, 2022:S1878-8750(22)01554-6→.
doi: 10.1016/j.wneu.2022.11.012→.
PMID: 36347463→.
Review˰ →
|
|
|
|
Seliger C, Oppong FB, Lefranc F, Chinot O, Stupp R, Nabors B,
Gorlia T, Weller M; EORTC Brain Tumor Group.
Research
Article: Association of antidepressant drug use with outcome of
patients with glioblastoma.
Int
J Cancer. 2022 Nov 8→.
doi: 10.1002/ijc.34344→.
PMID: 36346112→.
Pooled analysis. →
|
|
|
|
Adnani L, Spinelli C, Tawil N, Rak J.
Role
of extracellular vesicles in cancer-specific interactions between
tumour cells and the vasculature.
Semin
Cancer Biol. 2022 Nov 9, 2022:S1044-579X(22)00225-5→.
doi: 10.1016/j.semcancer.2022.11.003→.
PMID: 36371024→.
Review˰ →
|
|
|
|
Oztek MA, Noda SM, Romberg EK, Cole BL, Wright JN, Ishak GE, Perez
FA.
Changes to pediatric brain
tumors in 2021 World Health Organization classification of tumors
of the central nervous system.
Pediatr
Radiol. 2022 Nov 9→.
doi: 10.1007/s00247-022-05546-w→.
PMID: 36348014→.
Review˰ →
|
|
|
|
Chidley P, Shanker M, Phillips C, Haghighi N, Pinkham MB, Whittle
JR, Sia J.
Moderately
hypofractionated versus conventionally fractionated radiation
therapy with temozolomide for young and fit patients with
glioblastoma: an institutional experience and meta-analysis of
literature.
J
Neurooncol. 2022 Nov 10, 2022:1–14→.
doi: 10.1007/s11060-022-04151-z→.
PMID: 36355260→.
Observational study, Meta-analysis. →
|
|
|
*
|
Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan
B.
Research on application of tumor
treating fields in glioblastoma: A bibliometric and visual
analysis.
Front
Oncol. 2022 Nov 10, 2022;12:1055366→.
doi: 10.3389/fonc.2022.1055366→.
PMID: 36439464→.
Bibliometric analysis. →
Supplementary
materials→.
→
→
|
|
|
*
|
Li R, Huang Q, Ye C, Wu C, Luo N, Lu Y, Fang J, Wang
Y.
Bibliometric and visual analysis
in the field of ketogenic diet on cancer from 2012 to 2021.
Front
Nutr. 2022 Nov 10, 2022;9:1060436→.
doi: 10.3389/fnut.2022.1060436→.
PMID: 36438725→.
Bibliometric analysis. →
|
|
|
|
Yang Y, Schubert MC, Kuner T, Wick W, Winkler F, Venkataramani
V.
Brain Tumor Networks in Diffuse
Glioma.
Neurotherapeutics.
2022 Nov 10→.
doi: 10.1007/s13311-022-01320-w→.
PMID: 36357661→.
Review. →
|
|
|
|
Brennan PM.
The future of brain
tumor liquid biopsies in the clinic.
Neurooncol
Adv. 2022 Nov 11, 2022;4(S2):ii4-ii5→.
doi: 10.1093/noajnl/vdac091→.
PMID: 36380870→.
Opinion. →
|
|
|
|
Kizilbash SH.
Why has targeting EGFR
aberrations in glioblastoma therapy had limited success?
Expert
Rev Anticancer Ther. 2022 Nov 11→.
doi: 10.1080/14737140.2022.2146581→.
PMID: 36367033→.
Editorial. →
|
|
|
|
Mathios D, Phallen J.
Advances in
molecular biomarkers and liquid biopsy in gliomas.
Neurooncol
Adv. 2022 Nov 11, 2022;4(S2):ii15-ii21→.
doi: 10.1093/noajnl/vdac151→.
PMID: 36380861→.
Review. →
|
|
|
|
Westphal M, Pantel K, Ricklefs FL, Maire C, Riethdorf S, Mohme M,
Wikman H, Lamszus K.
Circulating
tumor cells and extracellular vesicles as liquid biopsy markers in
neuro-oncology: prospects and limitations.
Neurooncol
Adv. 2022 Nov 11, 2022;4(S2):ii45-ii52→.
doi: 10.1093/noajnl/vdac015→.
PMID: 36380859→.
Review. →
|
|
|
|
Luo J, Junaid M, Hamid N, Duan JJ,
Yang X, Pei DS.
Current
understanding of gliomagenesis: from model to mechanism.
Int
J Med Sci. 2022 Nov 14, 2022;19(14):2071-2079→.
doi: 10.7150/ijms.77287→.
PMID: 36483593→.
Review. →
|
|
|
|
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson
L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A,
Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F,
Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M,
Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP,
Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J,
Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E,
Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M,
Virolle T.
Challenges in
glioblastoma research: focus on the tumor microenvironment.
Trends
Cancer. 2022 Nov 15, 2022:S2405-8033(22)00220-5→.
doi: 10.1016/j.trecan.2022.09.005→.
PMID: 36400694→.
Review˰ →
|
|
|
|
Luo Y, Zhang S, Tan W, Lin G, Zhuang Y, Zeng H.
The
Diagnostic Efficiency of Quantitative Diffusion Weighted Imaging
in Differentiating Medulloblastoma from Posterior Fossa Tumors: A
Systematic Review and Meta-Analysis.
Diagnostics
(Basel). 2022 Nov 15, 2022;12(11):2796→.
doi: 10.3390/diagnostics12112796→.
PMID: 36428860→.
Review. →
|
|
|
|
Rajabian A, Farzanehfar M, Hosseini H, Arab FL, Nikkhah
A.
Boswellic acids as promising
agents for the management of brain diseases.
Life
Sci. 2022 Nov 15, 2022:121196→.
doi: 10.1016/j.lfs.2022.121196→.
PMID: 36400202→.
Review˰ →
|
|
|
|
Song P, Li H, Xu K, Li ZW, Ren X,
Fu XJ.
A
bibliometric and visualization-based analysis of temozolomide
research hotspots and frontier evolution.
Front
Oncol. 2022 Nov 15, 2022;12:905868→.
doi: 10.3389/fonc.2022.905868→.
PMID: 36457514→.
Bibliometric analysis. →
|
|
|
|
Yearley AG, Blitz SE, Patel RV, Chan A, Baird LC, Friedman GK,
Arnaout O, Smith TR, Bernstock JD.
Machine
Learning in the Classification of Pediatric Posterior Fossa
Tumors: A Systematic Review.
Cancers
(Basel). 2022 Nov 15, 2022;14(22):5608→.
doi: 10.3390/cancers14225608→.
PMID: 36428701→.
Review. →
|
|
|
|
|
|
|
|
|
|
|
